N[C@@H]1CCN(C2N=C3C(N=CN3[C@@H]3C[C@H](N4N=NC(CC)=N4)[C@@H](O)[C@H]3O)=C(NCC(C3C=CC=CC=3)C3C=CC=CC=3)N=2)C1.Cl.[C:46]1([CH:52]([C:93]2[CH:98]=[CH:97][CH:96]=[CH:95][CH:94]=2)[CH2:53][NH:54][C:55]2[N:63]=[C:62]([N:64]3[CH2:68][CH2:67][C@@H:66]([NH:69][C:70]([NH:72][C:73]4[CH:74]=[N:75][CH:76]=[CH:77][CH:78]=4)=[O:71])[CH2:65]3)[N:61]=[C:60]3[C:56]=2[N:57]=[CH:58][N:59]3[C@@H:79]2[CH2:83][C@H:82]([N:84]3[N:88]=[N:87][C:86]([CH2:89][CH3:90])=[N:85]3)[C@@H:81]([OH:91])[C@H:80]2[OH:92])[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=1>>[C:93]1([CH:52]([C:46]2[CH:47]=[CH:48][CH:49]=[CH:50][CH:51]=2)[CH2:53][NH:54][C:55]2[N:63]=[C:62]([N:64]3[CH2:68][CH2:67][C@@H:66]([NH:69][C:70]([NH:72][C:73]4[CH:74]=[N:75][CH:76]=[CH:77][CH:78]=4)=[O:71])[CH2:65]3)[N:61]=[C:60]3[C:56]=2[N:57]=[CH:58][N:59]3[C@@H:79]2[CH2:83][C@H:82]([N:84]3[N:88]=[N:87][C:86]([CH2:89][CH3:90])=[N:85]3)[C@@H:81]([OH:91])[C@H:80]2[OH:92])[CH:98]=[CH:97][CH:96]=[CH:95][CH:94]=1This compound is prepared from (1R,2S,3R,5S)-3-[2-((R)-3-amino-pyrrolidin-1-yl)-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(5-ethyl-tetrazol-2-yl)-cyclopentane-1,2-diol (Example 48), using a procedure analogues to that of 1-((R)-1-{6-(2,2-diphenyl-ethylamino)-9-[((1R,2S,3R,4S)-4-(5-ethyl-tetrazol-2-yl)-2,3-dihydroxy-cyclopentyl]-9H-purin-2-yl}-pyrrolidin-3-yl)-3-pyridin-3-yl-urea hydrochloride (Example 104). After purification, the compound is partitioned between DCM and saturated NaHCO3 (aq). The organics are dried (MgSO4), filtered and reduced in vacuo to yield the title compound. MS (ES+) m/e 716.51 (MH+).